This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1986 Jul 12;293(6539):88-9.

doi: 10.1136/bmj.293.6539.88.

Managing Raynaud's phenomenon

S Roath

PMID: 3089429
PMCID: PMC1340833
DOI: 10.1136/bmj.293.6539.88

Editorial

Managing Raynaud's phenomenon

S Roath. Br Med J (Clin Res Ed). 1986.

. 1986 Jul 12;293(6539):88-9.

doi: 10.1136/bmj.293.6539.88.

Author

S Roath

PMID: 3089429
PMCID: PMC1340833
DOI: 10.1136/bmj.293.6539.88

No abstract available

PubMed Disclaimer

Similar articles

[Raynaud's phenomena: diagnostic and treatment study].
Priollet P. Priollet P. Rev Prat. 1998 Oct 1;48(15):1659-64. Rev Prat. 1998. PMID: 9814067 Review. French.
[Understanding Raynaud's phenomenon: towards a better treatment].
Bart PA, Waeber B. Bart PA, et al. Rev Med Suisse. 2006 Jan 11;2(48):93-6. Rev Med Suisse. 2006. PMID: 16463792 Review. French.
Treatment of Raynaud's phenomenon.
García-Carrasco M, Jiménez-Hernández M, Escárcega RO, Mendoza-Pinto C, Pardo-Santos R, Levy R, Maldonado CG, Chávez GP, Cervera R. García-Carrasco M, et al. Autoimmun Rev. 2008 Oct;8(1):62-8. doi: 10.1016/j.autrev.2008.07.002. Epub 2008 Aug 8. Autoimmun Rev. 2008. PMID: 18692160 Review.
Raynaud's phenomenon.
Lally EV. Lally EV. Curr Opin Rheumatol. 1992 Dec;4(6):825-36. Curr Opin Rheumatol. 1992. PMID: 1457277 Review.
Managing Raynaud's phenomenon: a practical approach.
Adee AC. Adee AC. Am Fam Physician. 1993 Mar;47(4):823-9. Am Fam Physician. 1993. PMID: 8438681 Review.

See all similar articles

Cited by

Management of Raynaud's phenomenon. Focus on newer treatments.
Roath S. Roath S. Drugs. 1989 May;37(5):700-12. doi: 10.2165/00003495-198937050-00005. Drugs. 1989. PMID: 2663416 Review.
The effect of isradipine, a new calcium-channel antagonist, in patients with primary Raynaud's phenomenon: a single-blind dose-response study.
Leppert J, Jonasson T, Nilsson H, Ringqvist I. Leppert J, et al. Cardiovasc Drugs Ther. 1989 Jun;3(3):397-401. doi: 10.1007/BF01858110. Cardiovasc Drugs Ther. 1989. PMID: 2535054 Clinical Trial.
Nisoldipine in primary Raynaud's phenomenon.
Challenor VF, Waller DG, Francis DA, Francis JL, Mani R, Roath S. Challenor VF, et al. Eur J Clin Pharmacol. 1987;33(1):27-30. doi: 10.1007/BF00610375. Eur J Clin Pharmacol. 1987. PMID: 3691593 Clinical Trial.

References

1. Lancet. 1985 Jul 6;2(8445):50 - PubMed
1. Z Kardiol. 1985 May;74(5):298-302 - PubMed
1. J Clin Pharmacol. 1982 Jan;22(1):74-6 - PubMed
1. Lancet. 1983 Feb 12;1(8320):313-5 - PubMed
1. Br Med J (Clin Res Ed). 1984 Sep 8;289(6445):577-9 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central
Medical
- MedlinePlus Health Information